Ablation Technology Market Analysis

The market is segmented on type into radiofrequency, laser/light, ultrasound, electrical, cryoablation, microwave, hydrothermal, and others, out of which, the laser segment is anticipated to grab the largest share by the end of 2021 on account of being one of the minimally invasive procedures, the laser ablation technique is comparatively less painful to other surgical treatment options. This technique also causes very little damage to the surrounding tissues compared to other techniques. Moreover, technological developments are expected to drive the global laser ablation technology market.

Based on application, the cardiovascular disease treatment segment is projected to grow with a significant CAGR over the forecast period. The rising incidence of atrial fibrillation across the globe, coupled with the development of novel ablation technologies for the treatment of atrial fibrillation, is the major factor driving the market's growth.

Our in-depth analysis of the global market includes the following segments:

By Type	Radiofrequency Laser/light Ultrasound Electrical Cryoablation Microwave Hydrothermal Others
By Application	Cardiovascular disease treatment Ophthalmologic treatment Pain management Gynecological treatment Orthopedic treatment Others

Frequently Asked Questions (FAQ)

Rising occurrence of chronic disease such as cancer and emergence of next-generation ablation products and Technologies are the key factors driving market growth.

The market is anticipated to attain a moderate CAGR over the forecast period, i.e., 2021-2029.

Pricing and reimbursement issues and increasing regulatory agencies pressures are estimated to hamper market growth.

The market in Asia Pacific region will provide ample growth opportunities owing to factors such as increasing awareness, growing population, increasing income, eating habits, changing lifestyles, etc.

The major players dominating the non-metastatic castration resistant prostate cancer treatment market are Medtronic PLC, Biosense Webster Inc., St. Jude Medical, Inc., Boston Scientific Corporation, Angiodynamics, Inc., Atricure, Inc., Conmed Corporation, Olympus Corporation and others.

Ablation Technology Market Analysis